FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InTone^®MV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs. The InTone^®MV technology was developed by the makers of InTone^®, FDA listed as a Class II Medical Device for the treatment of female urinary incontinence.

"While InTone^® has helped countless women solve the embarrassing and uncomfortable issue of involuntary loss of urine, InTone^®MV allows us to help an even greater number of women who experience vaginal atrophy," said Herschel Peddicord, founder and CEO of InControl Medical. "Vaginal atrophy is a common complaint among menopausal women or those who have had a vaginal hysterectomy. Often atrophy is accompanied by incontinence and InControl recognized the need for a smaller device designed just for them."

Both the InTone^® and InTone^®MV devices combine muscle stimulation with voice-guided pelvic floor exercise, visual biofeedback, and a unique, customizable probe to create a home-based treatment for incontinence. This comprehensive approach provides users with an easy-to-use program without pain, pills or side-effects.